Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01

Part of paid clinical trials in Orange, California.

Sponsor
BlueRock Therapeutics
Study ID
NCT05897957
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 78 Years
Healthy Volunteers
Not accepted

Study Details

This is a multicenter study to evaluate the safety and clinical outcomes of BRT-DA01 in subjects with PD who previously received BRT-DA01 in the Phase 1 Study MSK-DA01-101.No investigational therapy will be administered in this study.

Key Dates

Start date
May 16, 2023
Status verified
Apr 2024
Primary completion
May 31, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
12 participants (estimated)

Primary Outcome Measure

Total SAEs and total number of subjects with at least 1 SAE [ Time Frame: Baseline through 5 years post-transplantation ]

Locations (2)

FacilityCityStateZIPSite coordinators
University of California, IrvineOrangeCalifornia92868-
Weill Cornell Medical CollegeNew YorkNew York10065-

Find similar trials in Orange, CA

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
University of California, Irvine· Orange, CAWeill Cornell Medical College· New York, NY

Related Studies